Work

Open label non-randomized multi-cohort pilot study of genetically engineered NY-ESO-1 specific NY-ESO-1c259 SPEAR T-cellsTM in HLA-A*02+ patients with synovial sarcoma (NCT01343043)

Year: 2016

Type: article

Source: Annals of Oncology

DOI: 10.1093/annonc/mdw378.29

Authors: C. Mackall, S. D'Angelo, S. Grupp, J. Glod, M. Druta, W. Chow, K. Chagin, M. Mehler, G. Kari, T. Trivedi, T. Holdich, L. Pandite, R. Amado

Institutions: Stanford Medicine, Stanford Cancer Institute, Memorial Sloan Kettering Cancer Center, Children's Hospital of Philadelphia, National Cancer Institute, Center for Cancer Research, Moffitt Cancer Center, City Of Hope National Medical Center, City of Hope, Adaptimmune (United Kingdom)

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2586688924

FWCI: 0.309

Cites:

Cited by: 2

Related to: 10